Abstract
In this study, the efficacy and safety of a treatment with the combination imidacloprid 10 %/ moxidectin 1.0 % spot-on (Advocate® spot-on for small cats and ferrets) was tested in 39 ferrets naturally infested with ear mites (Otodectes cynotis). The study was performed as a multicentre, non-randomised, non-controlled (all study animals were treated) and non-blinded clinical field study in two French veterinary practices. Four visits (day (D) 0 = inclusion and first treatment, D14 = second treatment, D28 = possible third treatment, D56 = termination) were planned. The dosage was one pipet per ferret (designed for cats weighing up to 4 kg, corresponding to a dose of moxidectin ranging from 2.2 to 5 mg/kg body weight) two or three times at 14-days intervals (at D0, D14 and possibly D28 depending on the parasitological examination of the ears at D28). The main efficacy criterion was the absence of the parasite (all stages incl. eggs, larvae, nymphs and adults) from ear scrapings by microscopic examination. At D28 after two treatments (D0 and D14), 76.9 % (30/39) of animals were cured. Only 23 % (9/39) needed a third treatment. At day 56, 100 % were cured. Local symptoms (inflammation and pruritus) were consistently improved (50.6 % improvement at D14, 81.0 % at D28 and 97.9 % at D56) as well as the abnormal cerumen production (14.7 % improvement at D14, 77.7 % at D28 and 100.0 % at D56). No general symptoms were noticed during the study (general health and skin aspect). Advocate® spot-on for small cats and ferrets is an effective and safe treatment for ear mite infection in ferrets. Two or three treatments administered in 14-days intervals to ferrets infested with ear mites provided 100 % parasitological cure on D56.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bensignor E, Chai N, Hadjaje C, Leguay E, Risi E, Schilleger L, Viaud S (2010) In: Dermatologie des NAC – Nouveaux Animaux de Compagnie et Animaux d’Espèces Inhabituelles ou Exotique, ed. Med’Com, p 24.
Boussarie D (2008) Guide pratique de médecine du furet, ed. Med’Com, Paris, France.
Davis W, Arther R, Settje T (2007) Clinical evaluation of the efficacy and safety of typically applied imidacloprid plus moxidectin against ear mites (Otodectes cynotis) in client-owned cats. Parasitol Res 101(1):19 – 24.
Farkas R, Germann T, Szeidemann Z (2007) Assessment of the ear mite (Otodectes cynotis) infestation and the efficacy of an imidacloprid plus moxidectin combination in the treatment of otoacariosis in a hungarian cat shelter. Parasitol Res 101 (Suppl 1):35 – 44.
Fischer M, Beck W, Hutchinson MJ (2007) Efficacy and safety of selamectin (Stronghold/ Revolution) used off-label in exotic pets. Int J Appl Res Vet Med 5:87 – 96.
Fourie L, Kok D, Heine J (2003) Evaluation of the efficacy of an imidacloprid 10 %/ moxidectin 1 % spot-on against Otodectes cynotis in cats. Parasitol Res 90(3):112 – 113.
Franc M (2005) Aspects cliniques des acarioses dues à Sarcoptes et Otodectes. Proceedings of the 6th Bayer Symposium on Ectoparasites, BSAVA Congress, Birmingham, UK.
Hansen O, Gall Y, Pfister K, Beck W (2005) Efficacy of a formulation containing imidacloprid and moxidectin against naturally acquired ear mite infestations (Psoroptes cuniculi) in rabbits. Int J Appl Res Vet Med 3(4):281 – 286.
Hubert B, Traina O, Magnol JP (2005) L’otocariose à Otodectes cynotis: une ectoparasitose aux multiples facettes. Prat Méd Chir Anim Comp 40:119 – 124.
Krieger K, Heine J, Dumont P, Hellmann K (2005) Efficacy and safety of imidacloprid 10 % plus moxidectin 2.5 % spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results of a European field study. Parasitol Res 97:81 – 88.
Lewington J (2007) Parasitic diseases of ferrets in ferret husbandry, medicine and surgery, 2nd edn. WB Saunders, pp 252 – 253.
Lohse J, Rinder H, Gothe R, Zahler M (2002) Validity of species status of the parasitic Otodectes cynotis. Med Vet Entomol 16:133 – 138.
Miller DS, Eagle RP, Zabel S, Rosychuk R, Campbell TW (2006) Efficacy and safety of selamectin in the treatment of Otodectes cynotis infestation in domestic ferrets. Vet Rec 159(22):748.
Orcutt CJ (2003) Dermatologic diseases of the ferret. In: Quesenberry KE, Carpenter JW (eds) Clinical medicine and surgery of ferrets, rabbits and rodents, 2nd edn. WB Saunders, Philadelphia, pp 107 – 114.
Otranto D, Milillo P, Mesto P, De Caprariis D, Perrucci S, Capelli G (2004) Otodectes cynotis (Acari: Psoroptidae): examination of survival off-the-host under natural and laboratory conditions. Exp Appl Acarol 32:171 – 179.
Schaper R, Heine J, Arther RG, Charles SD, McCall J (2007) Imidacloprid plus moxidectin to prevent heartworm infection (Dirofilaria immitis) in ferrets. Parasitol Res 101:57 – 62.
Wenzel U, Heine J, Mengel H, Erdmann F, Schaper R, Heine S, Daugschiess A (2008) Efficacy of imidacloprid 10 % / moxidectin 1 % (Advocate®/Advantage Multi™) against fleas Ctenocephalides felis felis) on ferrets (Mustela putorius furo). Parasitol Res 103(1):231–234.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Le Sueur, C., Bour, S. & Schaper, R. Efficacy and Safety of the Combination Imidacloprid 10 % / moxidectin 1.0 % Spot-on (Advocate® Spot-on for Small Cats and Ferrets) in the Treatment of Ear Mite Infection (Otodectes cynotis) in Ferrets. Parasitol Res 109 (Suppl 1), 149–156 (2011). https://doi.org/10.1007/s00436-011-2411-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-011-2411-7